Cairo-based startup Grinta, a fintech-enabled B2B technology platform focused on digitizing the pharmaceutical supply chain, has successfully secured an undisclosed amount of funding and made a significant acquisition as part of its strategy for further expansion.
Founded in 2021 by a team of innovators—Mohamed Azab, Yosra Badr, Ali Youssef, and Hamza Mohamed—Grinta operates as a managed marketplace that aims to modernize the pharmaceutical supply chain by empowering independent pharmacies. The platform offers an end-to-end solution that provides access to a comprehensive range of traceable pharmaceutical and medical products sourced from multiple vendors. In addition to product access, Grinta also offers services such as fulfillment, demand planning, and inventory financing, thereby streamlining operations for pharmacies.
Grinta collaborates with all stakeholders in the pharmaceutical value chain, including manufacturers, distributors, wholesalers, and pharmacies, to create a data-driven, reliable, and efficient supply chain. This collaborative approach is designed to enhance transparency and efficiency within the industry.
In late 2022, Grinta raised a notable seed round of US$8 million, which laid the groundwork for its subsequent growth. In 2023, the company made a strategic move by acquiring Auto-Cure, a B2B e-commerce platform, further solidifying its position in the market. Now, Grinta has announced additional funding and another acquisition to bolster its expansion efforts.
The latest funding round, led by Beltone Venture Capital and Raed Ventures, has resulted in an undisclosed amount of strategic investment. Alongside this, Grinta has acquired Citi Clinic, one of Egypt’s leading primary healthcare service chains. This acquisition provides Grinta with access to a patient base of over 150,000 individuals, marking a significant entry into the healthcare sector and reinforcing its commitment to integrating both online and offline healthcare solutions.
Mohamed Azab, co-founder and CEO of Grinta, expressed enthusiasm about the acquisition, stating, “The acquisition of Citi Clinic is a pivotal moment for Grinta. It not only enables us to enter the care market but also allows us to integrate offline and online services to transform the way healthcare is accessed and delivered. We are excited about what lies ahead as we expand our reach and impact.” This strategic move positions Grinta to enhance its service offerings and further its mission of revolutionizing healthcare access in the region.
